Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.
Hypervirulent strains of Clostridium difficile have emerged over the past decade, increasing the morbidity and mortality of patients infected by this opportunistic pathogen. Recent work suggested the major C. difficile virulence factor, TcdB, from hypervirulent strains (TcdB(HV)) was more cytotoxic in vitro than TcdB from historical strains (TcdB(HIST)). The current study investigated the in vivo impact of altered TcdB tropism, and the underlying mechanism responsible for the differences in activity between the two forms of this toxin. A combination of protein sequence analyses, in vivo studies using a Danio rerio model system, and cell entry combined with fluorescence assays were used to define the critical differences between TcdB(HV) and TcdB(HIST). Sequence analysis found that TcdB was the most variable protein expressed from the pathogenicity locus of C. difficile. In line with these sequence differences, the in vivo effects of TcdB(HV) were found to be substantially broader and more pronounced than those caused by TcdB(HIST). The increased toxicity of TcdB(HV) was related to the toxin's ability to enter cells more rapidly and at an earlier stage in endocytosis than TcdB(HIST). The underlying biochemical mechanism for more rapid cell entry was identified in experiments demonstrating that TcdB(HV) undergoes acid-induced conformational changes at a pH much higher than that of TcdB(HIST). Such pH-related conformational changes are known to be the inciting step in membrane insertion and translocation for TcdB. These data provide insight into a critical change in TcdB activity that contributes to the emerging hypervirulence of C. difficile.
Lanis
Jordi M
JM
Department of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Barua
Soumitra
S
Ballard
Jimmy D
JD
D000595:Amino Acid Sequence; D000818:Animals; D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D001427:Bacterial Toxins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D016466:CHO Cells; D002469:Cell Separation; D016360:Clostridioides difficile / Q000235:genetics / Q000378:metabolism* / Q000472:pathogenicity*; D006224:Cricetinae; D003412:Cricetulus; D005434:Flow Cytometry; D006863:Hydrogen-Ion Concentration; D008969:Molecular Sequence Data; D011487:Protein Conformation; D037521:Virulence Factors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D015027:Zebrafish
D001426:Bacterial Proteins; D001427:Bacterial Toxins; D037521:Virulence Factors; C031815:toxB protein, Clostridium difficile
Biochem Biophys Res Commun. 1998 Oct 9;251(1):100-5
9790914
Anaerobe. 2003 Dec;9(6):289-94
16887714
Nature. 2009 Apr 30;458(7242):1176-9
19252482
J Med Microbiol. 2004 Sep;53(Pt 9):887-894
15314196
J Med Microbiol. 2001 Jul;50(7):613-619
11444771
J Biol Chem. 2001 Apr 6;276(14):10670-6
11152463
Nature. 1995 Jun 8;375(6531):500-3
7777059
Lancet. 2005 Sep 24-30;366(9491):1079-84
16182895
Cell Microbiol. 2005 Aug;7(8):1139-49
16008581
J Bacteriol. 2006 Oct;188(20):7297-305
17015669
Mol Gen Genet. 1992 May;233(1-2):260-8
1603068
J Clin Microbiol. 2006 Jun;44(6):2147-52
16757612
J Biol Chem. 2007 Aug 31;282(35):25314-21
17591770
Infect Immun. 1998 Mar;66(3):1076-81
9488398
J Infect Dis. 2006 Apr 15;193(8):1143-50
16544255
Emerg Infect Dis. 2007 Mar;13(3):504-5
17552115
Gene. 1990 Nov 30;96(1):107-13
2148295
Infect Immun. 2000 May;68(5):2470-4
10768933
Glycobiology. 2008 Sep;18(9):698-706
18509107
Antimicrob Agents Chemother. 2006 Oct;50(10):3473-5
17005836
J Clin Microbiol. 2004 May;42(5):1933-9
15131151
J Med Microbiol. 2005 Feb;54(Pt 2):181-185
15673514
N Engl J Med. 2005 Dec 8;353(23):2442-9
16322602
Clin Infect Dis. 1992 Oct;15(4):573-81
1420669
Nature. 2007 Mar 22;446(7134):415-9
17334356
Infect Immun. 2001 Jan;69(1):599-601
11119561
Mol Microbiol. 1995 Jul;17(2):313-21
7494480
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84
9501201
PLoS Pathog. 2009 Oct;5(10):e1000626
19834554
Infect Control Hosp Epidemiol. 2005 Mar;26(3):273-80
15796280
J Biol Chem. 2000 May 5;275(18):13228-34
10788427
Genome Biol. 2009;10(9):R102
19781061
J Infect Dis. 2007 Dec 15;196(12):1813-9
18190262
Microbiology (Reading). 2005 Jan;151(Pt 1):199-208
15632438
J Bacteriol. 1992 Oct;174(20):6707-10
1307487
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14176-81
16966605
Infect Immun. 1978 May;20(2):526-9
669810
N Engl J Med. 2005 Dec 8;353(23):2433-41
16322603
J Clin Microbiol. 2008 Apr;46(4):1530-3
18287318
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12531-4
8901616
Br Med J. 1978 Mar 18;1(6114):695
630301
Microb Pathog. 1995 Oct;19(4):203-13
8825908
J Mol Biol. 2010 Mar 12;396(5):1260-70
20070948
BMC Infect Dis. 2009 Jun 28;9:103
19558711
J Biol Chem. 1997 Apr 25;272(17):11074-8
9111001
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7527-32
20368420
J Antimicrob Chemother. 2006 Dec;58(6):1264-7
17018563
J Biol Chem. 1998 Jul 31;273(31):19566-72
9677381
Mol Microbiol. 1991 Apr;5(4):797-803
1830357